At long last, Dexcom's Share app, which allows users to view and share data from their G5 continuous glucose monitors, will be available for Android users. The Android app just now received FDA ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.S. Centers for Medicare & Medicaid Services (CMS) is ...

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...

Here are three things to know. The Dexcom G5 mobile app allows patients to view and monitor glucose levels on their cell phones in real time. The approval makes Dexcom G5 the first continuous glucose ...

Traders raked in $4 billion in profit from their short positions in Tesla shares on Thursday after a public feud between President Donald Trump and CEO Elon Musk drove the biggest single-day drop in ...

The US Centers for Medicare & Medicaid Services (CMS) has modified its policy for coverage of continuous glucose monitors (CGMs) for diabetes to allow beneficiaries to use the devices with smartphones ...

This approval marks the Company’s fifth new insulin pump launch in only 5 years and the second featuring Dexcom technology. It is the only available pump that conveniently displays a user’s insulin ...

For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...